Imatinib Mesylate (Gleevec) Hepatotoxicity

By Mindikoglu Ayse   Regev Arie   Bejarano Pablo   Martinez Enrique   Jeffers Lennox   Schiff Eugene  

Digestive Diseases and Sciences, Vol. 52, Iss. 2, 2007-02 ,pp. : 598-601

Springer Publishing Company

Access to resources Recommend Favorite

ASBESTOS-INDUCED ACTIVATION OF CELL SIGNALING PATHWAYS IN HUMAN BRONCHIAL EPITHELIAL CELLS

By Wang Xinchao   Samet James   Ghio Andrew  

Experimental Lung Research, Vol. 32, Iss. 6, 2006-06 ,pp. : 229-243

Informa Healthcare

Access to resources Recommend Favorite

Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice

By Koyama Kensuke   Hatsushika Kyosuke   Ando Takashi   Sakuma Michitomo   Wako Masanori   Kato Ryohei   Haro Hirotaka   Sugiyama Hajime   Hamada Yoshiki   Ogawa Hideoki   Nakao Atsuhito  

Modern Rheumatology, Vol. 17, Iss. 4, 2007-08 ,pp. : 306-310

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension

By Chhina Mantej K   Nargues Weir   Grant Geraldine M   Nathan Steven D  

Future Cardiology, Vol. 6, Iss. 1, 2010-01 ,pp. : 19-35

Future Medicine

Access to resources Recommend Favorite

Imatinib Mesylate Does Not Increase Bone Volume In Vivo

By O’Sullivan Susannah  

Calcified Tissue International, Vol. 88, Iss. 1, 2011-01 ,pp. : 16-22

Springer Publishing Company

Access to resources Recommend Favorite